Ype P. de Jong

7.1k total citations · 6 hit papers
65 papers, 4.9k citations indexed

About

Ype P. de Jong is a scholar working on Epidemiology, Immunology and Genetics. According to data from OpenAlex, Ype P. de Jong has authored 65 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Epidemiology, 26 papers in Immunology and 20 papers in Genetics. Recurrent topics in Ype P. de Jong's work include Immune Cell Function and Interaction (17 papers), Hepatitis B Virus Studies (16 papers) and Virus-based gene therapy research (14 papers). Ype P. de Jong is often cited by papers focused on Immune Cell Function and Interaction (17 papers), Hepatitis B Virus Studies (16 papers) and Virus-based gene therapy research (14 papers). Ype P. de Jong collaborates with scholars based in United States, Netherlands and Israel. Ype P. de Jong's co-authors include Charles M. Rice, Cox Terhorst, Roland W. Herzog, Jamie L. Shirley, Alexander Ploß, Cox Terhorst, Maryline Panis, Matthew J. Evans, Valeriya Gaysinskaya and Hana You and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

Ype P. de Jong

63 papers receiving 4.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells

2009 704 citations Alexander Ploß, Ype P. de Jong et al. profile →
Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids

2018 588 citations Chenhui Zou, Corrine Quirk et al. Cell profile →
Immune Responses to Viral Gene Therapy Vectors

2020 537 citations Jamie L. Shirley, Ype P. de Jong et al. Molecular Therapy profile →
Hepatitis C Virus RNA Functionally Sequesters miR-122

2015 268 citations Joseph M. Luna, Troels K. H. Scheel et al. Cell profile →
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems

2014 196 citations Amir Shlomai, Vyas Ramanan et al. profile →
Broadly neutralizing antibodies abrogate established hepatitis C virus infection

2014 168 citations Ype P. de Jong, Marcus Dorner et al. Science Translational Medicine profile →

Peers

Ype P. de Jong

HEPAT

EPIDE

IMMUN

GENET

Nicola La Monica Italy

Sandra Hervás‐Stubbs Spain

Alana Althage United States

Andrew J. Syder United States

Chiaho Shih United States

Fumihiko Ishikawa Japan

Seishi Murakami Japan

Michael A. Brehm United States

Francisco Borrás‐Cuesta Spain

Hanspeter Pircher Switzerland

Nicola La Monica Italy

Ype P. de Jong

2.3k ×1.5

1.4k ×0.9

HEPAT

1.2k ×0.8

EPIDE

1.4k ×1.0

IMMUN

1.3k ×1.4

GENET

Citations per year, relative to Ype P. de Jong Ype P. de Jong (= 1×) peers Nicola La Monica

Countries citing papers authored by Ype P. de Jong

Since Specialization

Citations

This map shows the geographic impact of Ype P. de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ype P. de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ype P. de Jong more than expected).

Fields of papers citing papers by Ype P. de Jong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ype P. de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ype P. de Jong. The network helps show where Ype P. de Jong may publish in the future.

Co-authorship network of co-authors of Ype P. de Jong

This figure shows the co-authorship network connecting the top 25 collaborators of Ype P. de Jong. A scholar is included among the top collaborators of Ype P. de Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ype P. de Jong. Ype P. de Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Herzog, Roland W. & Ype P. de Jong. (2025). AAV vectors tested in perfused human livers. Nature Biotechnology. 43(12). 1931–1932. 1 indexed citations

Jong, Ype P. de, et al.. (2025). Gene-based therapies for steatotic liver disease. Molecular Therapy. 33(6). 2527–2547. 1 indexed citations

Kumar, Sandeep, Moanaro Biswas, Sreevani Arisa, et al.. (2023). TLR9-independent CD8+ T cell responses in hepatic AAV gene transfer through IL-1R1-MyD88 signaling. Molecular Therapy. 32(2). 325–339. 18 indexed citations

Lalazar, Gadi, Guangrong Zheng, Peiyi Zhang, et al.. (2022). Targeting BCL-XL in fibrolamellar hepatocellular carcinoma. JCI Insight. 7(17). 18 indexed citations

Chen, Zhouji, Zu‐Hua Gao, Ruishu Deng, et al.. (2022). Ectopic clotting factor VIII expression and misfolding in hepatocytes as a cause for hepatocellular carcinoma. Molecular Therapy. 30(12). 3542–3551. 21 indexed citations

Shirley, Jamie L., Ype P. de Jong, Cox Terhorst, & Roland W. Herzog. (2020). Immune Responses to Viral Gene Therapy Vectors. Molecular Therapy. 28(3). 709–722. 537 indexed citations breakdown →

Stevens, Kelly R., Margaret A. Scull, Vyas Ramanan, et al.. (2017). In situ expansion of engineered human liver tissue in a mouse model of chronic liver disease. Science Translational Medicine. 9(399). 131 indexed citations

Andréo, Ursula, Ype P. de Jong, Margaret A. Scull, et al.. (2017). Analysis of Hepatitis C Virus Particle Heterogeneity in Immunodeficient Human Liver Chimeric fah-/- Mice. Cellular and Molecular Gastroenterology and Hepatology. 4(3). 405–417. 4 indexed citations

Mendoza, Juan L., William M. Schneider, Hans-Heinrich Hoffmann, et al.. (2017). The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity. Immunity. 46(3). 379–392. 86 indexed citations

10.

Perrin, George Q., Irene Zolotukhin, Alexandra Sherman, et al.. (2016). Dynamics of antigen presentation to transgene product-specific CD4+ T cells and of Treg induction upon hepatic AAV gene transfer. Molecular Therapy — Methods & Clinical Development. 3. 16083–16083. 35 indexed citations

11.

Billerbeck, Eva, Michiel C. Mommersteeg, Amir Shlomai, et al.. (2016). Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells. Journal of Hepatology. 65(2). 334–343. 65 indexed citations

12.

Luna, Joseph M., Troels K. H. Scheel, Tal Danino, et al.. (2015). Hepatitis C Virus RNA Functionally Sequesters miR-122. Cell. 160(6). 1099–1110. 268 indexed citations breakdown →

13.

Shlomai, Amir, Ype P. de Jong, & Charles M. Rice. (2014). Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma. Seminars in Cancer Biology. 26. 78–88. 139 indexed citations

14.

Jesudian, Arun, Ype P. de Jong, & Ira M. Jacobson. (2013). Emerging Therapeutic Targets for Hepatitis C Virus Infection. Clinical Gastroenterology and Hepatology. 11(6). 612–619.e1. 11 indexed citations

15.

Billerbeck, Eva, Ype P. de Jong, Marcus Dorner, Cynthia de la Fuente, & Alexander Ploß. (2013). Animal Models for Hepatitis C. Current topics in microbiology and immunology. 369. 49–86. 66 indexed citations

16.

Shah, Samir A., Stephen J. Simpson, Lawrence F. Brown, et al.. (2007). Development of colonic adenocarcinomas in a mouse model of ulcerative colitis. Inflammatory Bowel Diseases. 4(3). 196–202. 3 indexed citations

17.

Jong, Ype P. de. (2004). Blocking inducible co-stimulator in the absence of CD28 impairs Th1 and CD25+ regulatory T cells in murine colitis. International Immunology. 16(2). 205–213. 29 indexed citations

18.

Saubermann, Lawrence J., Paul L. Beck, Ype P. de Jong, et al.. (2000). Activation of natural killer T cells by α-galactosylceramide in the presence of CD1d provides protection against colitis in mice. Gastroenterology. 119(1). 119–128. 175 indexed citations

19.

Shah, Samir A., Stephen J. Simpson, Lawrence F. Brown, et al.. (1998). Development of Colonic Adenocarcinomas in a Mouse Model of Ulcerative Colitis. Inflammatory Bowel Diseases. 4(3). 196–202. 22 indexed citations

20.

Simpson, Stephen J., Ype P. de Jong, Martina Comiskey, & Cox Terhorst. (1998). T Cells in Mouse Models of Gut Inflammation. PubMed. 71. 118–138. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact